How should access to antiretroviral treatment be measured?
Johnson, L.F.; Boulle, A.
Bulletin of the World Health Organization 89(2): 157-160
2011
ISSN/ISBN: 1564-0604 PMID: 21346928 Document Number: 223753
Document emailed within 1 workday
Related Documents
Azétsop, J.; Diop, B.A. 2013: Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy? Philosophy Ethics and Humanities in Medicine: Pehm 8: 8Azétsop, J.; Diop, B.A. 2013: Access to antiretroviral treatment, issues of well-being and public health governance in Chad: what justifies the limited success of the universal access policy? Philosophy Ethics and Humanities in Medicine: Pehm 8: 8
Chequer, P.; Cuchí, P.; Mazin, R.; García Calleja, J.M. 2002: Access to antiretroviral treatment in Latin American countries and the Caribbean Aids 16 Suppl. 3: S50-S57
Chequer, P.; Cuchí, P.; Mazin, R.; García Calleja, J.M. 2002: Access to antiretroviral treatment in Latin American countries and the Caribbean Aids 16 Suppl. 3: S50-S57
Cleary, S.; McIntyre, D. 2010: Financing equitable access to antiretroviral treatment in South Africa Bmc Health Services Research 10(Suppl 1): S2
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Medoua, G.N.; Ndzana Abomo, A.C.; Essa'a, V.J.; Sobgui, C.M.; Messomo, M.T.G.; Rikong, H.A. 2008: Validity of impedance-based equations for the prediction of total body water as measured by deuterium dilution in Cameroonian HIV-infected patients treated with antiretroviral treatment Clinical Nutrition 27(6): 881-888
Shah, S.; Elmer, S.; Grady, C. 2009: Planning for Posttrial Access to Antiretroviral Treatment for Research Participants in Developing Countries American Journal of Public Health (1971) 99(9): 1556-1562
Dhamija, P.; Bansal, D.; Medhi, B. 2009: Trends and economic stress: a challenge to universal access to antiretroviral treatment in India Current HIV Research 7(4): 410-417
Seeling, S.; Mavhunga, F.; Thomas, A.; Adelberger, B.; Ulrichs, T. 2014: Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia International Journal of Mycobacteriology 3(4): 268-275
Nguyen, N.Thi.Thu.; Rasch, V.; Bygbjerg, I.Christian.; Mogensen, H.Overgaard. 2013: Vietnamese women's struggle to access antiretroviral drugs in a context of free treatment Health Care for Women International 34(3-4): 209-226
Taieb, F.; Aghokeng, A.F.; Eymard-Duvernay, S.; Chia, J.E.; Einterz, E.; Mpoudi-Ngole, E.; Peeters, M.; Molina, J.-M.; Delaporte, E. 2014: Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa Aids Research and Human Retroviruses 30(7): 623-625
Chakrapani, V.; Newman, P.A.; Shunmugam, M.; Kurian, A.K.; Dubrow, R. 2009: Barriers to free antiretroviral treatment access for female sex workers in Chennai, India Aids Patient Care and Stds 23(11): 973-980
Thai, S.; Koole, O.; Un, P.; Ros, S.; De Munter, P.; Van Damme, W.; Jacques, G.; Colebunders, R.; Lynen, L. 2009: Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia Tropical Medicine and International Health: Tm and Ih 14(9): 1048-1058
Railton, J.; Mash, R. 2012: How children access antiretroviral treatment at Kgapane District Hospital, Limpopo, South Africa South African Family Practice 54(3): 229-236
Ventelou, B.; Arrighi, Y.; Greener, R.; Lamontagne, E.; Carrieri, P.; Moatti, J.-P. 2012: The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model PLOS one 7(4): E34101
Aghokeng, A.F.; Mpoudi-Ngole, E.; Dimodi, H.; Atem-Tambe, A.; Tongo, M.; Butel, C.; Delaporte, E.; Peeters, M. 2009: Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon Plos one 4(11): E7702
Hussain, A.; Moodley, D.; Naidoo, S.; Esterhuizen, T.M. 2011: Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment PLOS one 6(12): E27907
Jacobs, N.; Schneider, H.; Van Rensburg, H.C.J. 2008: Rationing access to public-sector antiretroviral treatment during scale-up in South Africa: implications for equity African Journal of Aids Research: Ajar 7(1): 19-27
Ingle, S.M.; May, M.; Uebel, K.; Timmerman, V.; Kotze, E.; Bachmann, M.; Sterne, J.A.C.; Egger, M.; Fairall, L. 2010: Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study South African Medical Journal 100(10): 675-681